Disease mapping is the study of the distribution of disease relative risks or rates in space and time, and normally uses generalized linear mixed models (GLMMs) which includes fixed effects and spatial, temporal, and spatio-temporal random effects. Model fitting and statistical inference are commonly accomplished through the empirical Bayes (EB) and fully Bayes (FB) approaches. The EB approach usually relies on the penalized quasi-likelihood (PQL), while the FB approach, which has increasingly become more popular in the recent past, usually uses Markov chain Monte Carlo (McMC) techniques. However, there are many challenges in conventional use of posterior sampling via McMC for inference. This includes the need to evaluate convergence of posterior samples, which often requires extensive simulation and can be very time consuming. Spatio-temporal models used in disease mapping are often very complex and McMC methods may lead to large Monte Carlo errors if the dimension of the data at hand is large. To address these challenges, a new strategy based on integrated nested Laplace approximations (INLA) has recently been recently developed as a promising alternative to the McMC. This technique is now becoming more popular in disease mapping because of its ability to fit fairly complex space-time models much more quickly than the McMC. In this paper, we show how to fit different spatio-temporal models for disease mapping with INLA using the Leroux CAR prior for the spatial component, and we compare it with McMC using Kenya HIV incidence data during the period 2013-2016.
Introduction
Statistical methods for disease mapping have grown very fast in the last decade.
Modern registers provide a lot of information with high quality data recorded for different regions over a period of time (e.g. years). This has brought in new challenges and goals which also require new and more flexible statistical models, faster and less computationally demanding methods for model fitting, and advance softwares to implement them. Spatio-temporal disease mapping models are widely used to describe the temporal variation and geographical patterns of mortality risks or rates. The information obtained from these analyses is useful for health researchers and policy makers since it helps in formulating hypothesis about the aetiology of a disease, looking for risk factors and also allocation of resources efficiently in hot spot areas, or planning prevention and intervention measures.
Spatio-temporal models are mainly used in disease mapping studies because they make it possible to borrow strength from spatial and temporal neighbours to reduce the high variability that is common to classical risk estimators, such as the standardized mortality ratio (SMR) when studying, in particular, rare diseases or low populated areas. These models are usually formulated in a hierarchical Bayesian framework and typically rely on generalized linear mixed models (GLMM). Model fitting and statistical inference are commonly accomplished through the empirical Bayes (EB) and fully Bayes (FB) approaches. The EB approach usually relies on the penalized quasi-likelihood (PQL) [1] , while the FB approach usually uses Markov chain Monte Carlo (McMC) techniques [2] . Both approaches have been used in the literature and both have advantages and disadvantages [3] , but the FB approach has experienced an enormous expansion due to the advent of modern computers and free software to run McMC algorithms such as WinBUGS [4] .
The FB approach provides posterior marginal distributions of the target parameters and consequently it provides a whole picture about the target parameters instead of a single point estimate. However, there are many challenges associated with this approach. The posterior sampling distributions are not readily available in a closed form and hence inference is usually achieved via McMC algorithms. This includes the need to evaluate convergence of posterior samples, which often requires extensive simulation and can be very time consuming. Spatio-temporal models used in disease mapping are often very complex and McMC methods may lead to large Monte Carlo errors and large computation time if the dimension of the data at hand is large [5] . Moreover, the available software do not implement easily specific algorithms that are often needed [6] . Hence, there is a need to strike a balance between the exact inference, model complexity and computing time. This is also an issue in spatio-temporal disease mapping where the data at hand are usually large and the models are complex. Additionally, there is also a challenge in choosing priors for the hyper parameters in order to obtain reliable inference [7] [8] . INLA also has an additional attractive feature since it can be easily used in the free software [10] , with the package R-INLA [11] .
There is an extensive literature in Bayesian spatio-temporal disease mapping.
For parametric models, see for example [12] [13] [14] and Knorr-Held and Besag [15] for non-parametric time trends models. A major contribution to spatio-temporal disease mapping is a research paper byKnorr-Held [16] , which describes four different types of space-time interactions. Most of the previous work in disease mapping is based on the popular conditional autoregressive priors (CAR) to model both the spatial and temporal effects extending the initial work of Besag, York, J. and Mollie [17] . However, there are other approaches based on splines that have been developed. For example, within an EB frame work, MacNab and Dean [18] proposed autoregressive local smoothing in space and B-spline smoothing for time. On the other hand, Ugarte, Goicoa, and Militino [19] and Ugarte, Goicoa, and Etxeberria [20] used a pure interaction P-spline model for space and time, while Ugarte, Goicoa, and Etxeberria [21] consider an ANOVA type P-spline model to study spatio-temporal patterns of prostate cancer mortality in Spain. From a FB frame work, see MarNab [22] and MacNab, and Gustafson [23] for the application of spline smoothing in disease mapping.
In this paper, our focus is to implement spatio-temporal disease mapping models using the INLA methodology. Most of the research in spatial and spatio-temporal disease mapping with INLA considers the Besag et al. [17] [31] , LCAR hereafter in this paper. This prior has been proved to be better than the ICAR prior [32] and can be easily implemented using the R-INLA package. This model has previously been used to construct a local adaptive algorithm for spatial smoothing [33] .
where α is the global risk and i u is the spatially structured random effect.
Very often, an intrinsic conditional autoregressive (ICAR) prior is used to modeled the vector of spatially structured random effects
where − denotes the Moore-Penrose inverse of a matrix, , , , , ,
can be expressed as follows:
However, this model has been criticized since the spatial and non-spatial effects are not identifiable, as noticed by Eberly and Carlin [34] . To fix these identifiability problems, Leroux [31] considered the following LCAR prior that takes into account spatially structured and unstructured variability: 
Suppose now that for every small area i, data has been recorded for different time 
here,
( )
log it θ can be specified in different ways to define various models.
Various spatio-temporal models for disease mapping have been considered in the literature, with most of them based on the popular ICAR models extending the popular BYM model [17] . In this section, we discuss three models with parametric time trends and a set of non-parametric models that include different types of space-time interactions [16] . The INLA methodology will be used to fit these models.
Linear Time Trend Models
In this section, we consider a Bayesian model with a parametric linear trend for the temporal component which is with the model proposed by Bernardinelli [12] .
This model is just an extension of the BYM spatial model but with an additional linear time trend and a differential time trend for each small area. The logarithm of the relative risks are modelled as follows;
where α is the intercept that quantifies the average outcome rate in the entire study region, i u is the spatial random effect, β is the main linear time trend which represents the global time effect, and i δ is a differential trend which captures the interaction between the linear time trend and the spatial effect i u .
In this paper, the LCAR prior proposed by Leroux [31] is considered for the 
Nonparametric Dynamic Time Trend Models
In the model specified above, a linearity assumption imposed on the differential necessary to extend Equation (9) by releasing out the linearity constraint and assuming a dynamic non-parametric trends. In this paper, various non-parametric models which also includes space-time interactions are examined. In these models, the LCAR prior distribution is used for the spatial component unlike the models considered by Knorr-Held [16] in which an ICAR prior distribution is used for the spatial component. Here, the logarithm of the relative risk is model as;
( )
here α and i u have the same parameterization as in Equation (9). The term σ is the variance parameter and δ R is the structure matrix given by the Kronecker product of the corresponding structure matrices which identify the type of the temporal and/or spatial main effects which interact [37] .
There are four ways to define the structure matrix, as presented in Knorr-Held [16] and reported in Table 1 
interpreted as different spatial trends for each year without any temporal structure. Type IV interaction, which is the most complex among the space-time interactions, assumes that s it δ ′ are completely dependent over space and time.
This type of interaction will be appropriate if temporal trends are different from region to region, but are more likely to be similar for adjacent regions. Table 1 gives a summary of the structure matrices for the different type of space-time interactions and the rank deficiencies. To ensure identifiability of the interaction term δ in case of rank deficiency, specific sum-to-zero constraints have to be used. If these constraints are not included then the interaction terms are confounded with the main time effect γ . It is only the Type I interaction which does not need additional constraints as this prior does not induce a rank deficiency, see Table 1 .
Different combinations of priors for the temporally structured effect (RW1 or RW2) and the type of interaction produce 20 additional models to models 1, 2a, and 2b discussed in Section 2.1. Models 3a and 3b are the additive models (obtained when the interaction term is dropped) with RW1 and RW2 for the temporally structured effect, respectively. Models 4a and 4b are Type I interaction models with RW1 and RW2 for the temporally structured effect, respectively. Models 5a and 5b are the same as models 4a and 4b but with a Type II interaction. Models 6a and 6b are Type III interaction models, and Models 7a and 7b include a Type IV interaction. In addition, models without the unstructured temporal effect are considered. Models 8a and 8b are additive models with RW1 and RW2 priors for the temporally structured effect. Models 9a and 9b are Type I interaction models, Models 10a and 10b are Type II interaction, Models 11a and 11b include a Type III interaction models and Models 12a and 12b are the Type IV interaction models.
Bayesian Inference Using Integrated Nested Laplace Approximations (INLA)
The Bayesian inference using INLA methodology is implemented in a package called inla, which is a C program [11] . This program is based on the GRMFLib-library, which incorporates efficient algorithms for sparse matrices [36] . Here, the computations are speeded up by the implementation of parallel The models in INLA can be ran by specifying the linear predictor of the model as a formula object in R using the function f() for the smooth effects such as fixed effects, non linear terms and random effects. The interface is very flexible and it has options that allows different models and priors to be specified easily. section, only an overview of the spatial models that will be used to fit the models considered in this paper will be provided. Spatial latent effects for the lattice data in R-INLA consist of a prior distribution which follow a multivariate normal distribution with zero mean and precision matrix τ C , where τ is a precision parameter and C is a square and symmetric structure matrix which controls how the spatial dependence is and it can assume different forms to induce different types of spatial interaction. When C is completely specified, like in the case of spatio-temporal interaction effect, the "generic0" model is implemented and it defines a multivariate normal prior distribution with zero mean and generic precision matrix C which is normally defined by the user.
For the case of spatially structured random effect, the "besag" and "generic1" models are used to implement the ICAR [17] and LCAR [31] prior distributions respectively. The besag model for the ICAR prior corresponds to a multivariate normal with zero mean and precision matrix τ R , with ij R equal to i n if i j = , −1 if ĩ j and 0 otherwise, where i n is the number of neighbours of county i and and ĩ j indicates that counties i and j are neighbours. On the other hand, the LCAR prior, which forms the basis of the space-time disease mapping models discussed in this paper, can not be obtained directly in R-INLA, but the generic1 model can be used to introduce it easily. This model implements a multivariate normal distribution with zero mean and precision matrix τ Q , with
where C is the structure matrix and max λ is the maximum eigenvalue of matrix C which allows the parameter β take values between 0 and 1. Ugarte [38] show that when = − C I R then max 1 λ = . Hence, the LCAR model In addition to the ICAR specification implemented in the besag model, bym model can be used to implement the sum of spatially structured and [17] . Similarly, for the spatially structured temporal random effects, the first and second order random walk priors are implemented using "rw1" and "rw2" models respectively.
Finally, the identically independent random effects can be implemented using the "iid" model. In all these models, only the priors corresponding to the precision parameters (the inverse of the variance components) should be specified. In this paper, the following precision parameters are considered: To ensure the identifiability of the interaction term δ , it should be emphasized here that sum-to-zero constraints should be used depending on the type of interaction (see Table 1 ). The vector δ follows an IGMRF which is improper, i.e. its precision matrix or equivalently its structure matrix δ R is not of full rank. Its improper distribution denoted by ( ) π * δ is written as
where = A e δ denotes linear constraints on δ with A given by those eigenvectors of δ R which span the null space. Hence, to ensure the identifiability of δ , the null space of the respective structure matrix δ R is computed using the obtained eigenvectors as linear constraints for the estimation of δ . Consequently, the number of linear constraints which are necessary is always equal to the rank deficiency of δ R (see Table 1 ) and e will be a vector of zeros.
In R-INLA, the model is normally fitted with a call to function inla(), which returns an inla object with the fitted model. This function provides for specification of different likelihood models (family object), computes marginal densities of the latent effects and, by default, the hyperparameters and also enables one to select the integration strategy for the approximations (control.inla object). In addition to the posterior marginal densities, it is possible to compute posterior marginals for the linear predictor (control.predictor object). Several quantities for model choice and selection such as the effective number of parameters (pD) and the Deviance Information Criterion (DIC) are also provided within INLA (control.compute object).
Prior Distributions
The choice of prior distributions is very important in Bayesian inference because it can seriously affect the posterior distributions. The hyperprior distributions are defined in R-INLA with the argument hyper. Here, the hyperprior distributions for the spatial components are ( ) parameters can be obtained inWakefield [7] andFong [8] , among other papers.
Finally, a Gaussian exchangeable prior with mean 0 and variance 1000 is used for the fixed effect.
Application to HIV Incidence Data
In this section we apply the models discussed in the previous sections to . The best fitting model is one with the smallest DIC value. In our analysis in this paper, all models were fitted using the Simplified Laplace approximations strategy. Table 2 shows D , pD and the DIC values for the 23 fitted models discussed in Section 2. It can be seen that while parametric models and the additive models can arise due to factors associated to a specific area; a temporal risk trend common to all regions (γ ) that can arise due to changes in coding the disease, diagnostics, policies affecting the whole country and finally a region specific temporal risk trend δ attributed to specific effects of each county. Figure 1 shows the spatial and temporal patterns for HIV cases in Kenya. Figure 1 (upper left figure) shows the spatial incidence risk Figure 1 (upper right figure) shows the posterior probability that the spatial risk is greater than 1 ( ) ( )
Probabilities above 0.9 point towards high risk areas. Some discussions about reference thresholds in relative risks and cut-off probabilities can be obtained in Richardson, Thomson, and Best [43] , Ugarte et al. [13] , and Ugarte, Goicoa, and Militino [44] .
It is clear from this figure that there is a higher risk of HIV infection in the counties to the Western region of Kenya as compared to the other counties. In particular, Homa Bay, Siaya, Migori and Kisumu counties show high relative risks. Finally, Figure 1 (bottom figure) shows the temporal risk trend common to all counties. Generally, there is an increasing trend in the whole period which indicates that there might be some factors affecting the whole country that produce an increase in risk along the period. There is a non-linear trend ( )
1|
it P r Y > posterior probability distribution by counties. 
Conclusions
Spatial and spatio-temporal models are usually formulated in a hierarchical Most of the works in spatial and spatio-temporal disease mapping with McMC and INLA considers the intrinsic conditional autoregressive (ICAR) prior for the spatially structured variability. However, the ICAR prior is improper and has the undesirable largescale property of leading to a negative pairwise correlation for regions located further apart. Moreover, the variance components in the BYM convolution model are not identifiable from the data and informative hyperpriors are needed for posterior inference. In this paper, we consider the LCAR prior as an alternative to the ICAR prior. The LCAR prior does not produce such negative correlations and has the advantage of including a parameter that quantifies spatial dependence as well as unstructured heterogeneity. A comparison of INLA and McMC has been done using the LCAR prior for the spatial random effects. WinBUGS is a populal tool for analysis in FB disease mapping while INLA was recently introduced and is now gaining popularity. Both techniques produce similar parameter estimates, except for the smoothing parameter, where McMC tends to overestimate it a bit more than INLA. To improve the models in INLA, we explore specifying the use of a full Laplace approximation strategy, but this does not lead to different parameter estimates and computation time is longer as compared to simple Laplace approximation. Specifying the full Laplace strategy did, however, lead to different goodness of fit measures that were closer to those produced with WinBUGS.
Finally, our analysis of the Kenya HIV incidence data for the period 2013-2016 shows that the incidence rate is still high, and counties located to the Western region show a significant high risk as compared with the other counties. In particular, Homa Bay, Siaya, Migori and Kisumu counties shows the highest risks. The reasons why these counties show high HIV incidence risks is a subject that is still under investigation and further research is needed.
